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Background: While Web-based interventions have been shown to assist a wide range 
of patients successfully in managing their illness, few studies have examined the 
relative contribution of different Web-based components to improve outcomes. 
Further efficacy trials are needed to test the effects of Web support when offered as a 
part of routine care. 
Objective: Our aim was to compare in regular care the effects of (1) an Internet-
based patient provider communication service (IPPC), (2) WebChoice, a Web-based 
illness management system for breast cancer patients (IPPC included), and (3) usual 
care on symptom distress, anxiety, depression, (primary outcomes), and self-efficacy 
(secondary outcome). This study reports preliminary findings from 6 months’ follow-
up data in a 12-month trial. 
Methods: We recruited 167 patients recently diagnosed with breast cancer and 
undergoing treatment from three Norwegian hospitals. The nurse-administered IPPC 
allowed patients to send secure e-messages to and receive e-messages from health 
care personnel at the hospital where they were treated. In addition to the IPPC, 
WebChoice contains components for symptom monitoring, tailored information and 
self-management support, a diary, and communication with other patients. A total of 
20 care providers (11 nurses, 6 physicians, and 3 social workers) were trained to 
answer questions from patients. Outcomes were measured with questionnaires at 
study entry and at study months 2, 4, and 6. Linear mixed models for repeated 
measures were fitted to compare effects on outcomes over time. 
Results: Patients were randomly assigned to the WebChoice group (n=64), the IPPC 
group (n=45), or the usual care group (n=58). Response rates to questionnaires were 
73.7% (123/167) at 2 months, 65.9 (110/167) at 4 months, and 62.3% (104/167) at 6 
months. Attrition was similar in all study groups. Among those with access to 
WebChoice, 64% (41/64) logged on more than once and 39% (25/64) sent e-
messages to care providers. In the IPPC group, 40% (18/45) sent e-messages. 
Linear mixed models analyses revealed that the WebChoice group reported 
significantly lower symptom distress (mean difference 0.16, 95% CI 0.06-0.25, 
P=.001), anxiety (mean difference 0.79, 95% CI 0.09-1.49, P=.03), and depression 
(mean difference 0.79, 95% CI 0.09-1.49, P=.03) compared with the usual care 
group. The IPPC group reported significant lower depression scores compared with 
the usual care group (mean difference 0.69, 95% CI 0.05-1.32, P=.03), but no 
differences were observed for symptom distress or anxiety. No significant differences 
in self-efficacy were found among the study groups. 
Conclusions: In spite of practice variations and moderate use of the interventions, our 
results suggest that offering Web support as part of regular care can be a powerful 
tool to help patients manage their illness. Our finding that a nurse-administered IPPC 
alone can significantly reduce depression is particularly promising. However, the 
multicomponent intervention WebChoice had additional positive effects. 
Trial Registration: Clinicaltrials.gov:NCT00971009; 
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Introduction 
The number of Web-based support systems to enhance self-management for people 
living with health conditions has increased rapidly in the last decade, and such 
interventions have been shown to assist a wide range of patients [1-11]. In cancer 
care, Web-based support systems are described as helpful for individuals [12]. This 
includes findings of increased health information competence [13,14], emotional 
processing [13], fighting spirit [15], social support [14,16], quality of life [16,17], as 
well as reductions in symptom distress [18,19], and decrease in depression and 
anxiety scores [17]. 
However, it can be difficult to distinguish which components of Web-based support 
systems are most beneficial for patients, and little is known about the relative 
contribution of different components [13]. In a study of a support system for cancer 
patients by Baker et al, different features of the system were tested and compared 
[13]. Results suggested that the benefit of the system was connected to the 
information (information about cancer, Web links, news, etc) and support services 
(support from peers and professionals), and that complex services such as coaching 
and tailoring of content did not produce benefits beyond simple access to the 
Internet. Another study of the same support system highlighted that benefits depend 
on how a patient uses a system, far more than the total amount of exposure or type 
of content that is chosen [20]. Overall time spent on the system showed no relation to 
outcomes. Improvement in patient status was connected to the commitment to use 
the system over time, independent of how much time they spent on the system. 
However, high use of communication services (discussion groups and “ask experts or 
peers”) were associated with decreased negative emotions. Knowledge of the use 
and effects of single components on patient outcomes will be important to determine 
component candidates for inclusion in Web-based support systems [13,16,21]. 
One component often offered as part of multicomponent systems, or as a standalone 
service, is e-messages. Several studies report benefits from using Internet-based 
patient-provider communication services (IPPC) for communication between patients 
and health care providers in terms of assisting patients in managing illness and 
improving health outcomes [22-24], addressing unmet communication needs [25,26], 
increasing satisfaction [23,27], and improving quality of care [22,27]. Most of these 
studies used IPPCs between patients and physicians. In an earlier study of 
WebChoice, the same Web-based support system for cancer patients used in this 
study, the nurse-administered IPPC was used by patients to ask questions and raise 
concerns related to symptom experiences, fear of relapses, and uncertainty in 
everyday life [18,28]. The IPPC was rated by patients as the most valuable 
component of WebChoice [29]. High levels of satisfaction with a nurse-administered 
IPPC were also reported in a study by Cornwall et al [30], but effects on patients’ 
outcomes of IPPCs alone are rarely described. Thus, we know little about the effect 
of standalone IPPCs and patient outcomes and how they compare to more 
comprehensive Web-based support systems where IPPCs are one of several 
components. In addition, as Web-based support systems require many resources in 
system development and updating compared to an IPPC, it is interesing to test the 
effects of these two intervention types compared to usual care. 
WebChoice is a Web-based illness management support system based on patient-
centered principles and designed to support cancer patients in self-management of 
their illness, independent of location and time [31]. The purpose of WebChoice is to 
help cancer patients reduce their symptom distress, improve emotional well-being, 
and enhance self-efficacy. Results from a previously randomized clinical trial (RCT) 
that followed 325 breast cancer and prostate cancer patients for 1 year showed that 
patients with access to WebChoice had significantly reduced symptom distress 
compared with the usual care control group [18]. Patients in the WebChoice group 
also had significant within-group improvements in depression during the study period. 
In addition, the control group experienced significant deterioration in self-efficacy and 
health-related quality of life during the study. One of the WebChoice features most 
valued by the study participants, as reported in the previous study, was the 
opportunity to send e-messages to expert nurses in cancer care, who responded to 
patients’ questions and concerns within 24 hours [29]. In the RCT described above, 
WebChoice was offered as a service to patients independent of location and clinical 
practice. The patients were recruited through advertisements and postal mail. The 
nurses who answered the e-messages had no treatment responsibilities and did not 
know the patients. Thus, so far we do not know if similar effects would be achieved if 
WebChoice or an IPPC were offered as an integrated part of regular care. 
As several studies show benefits to Web-based support systems, it is timely to 
examine the relative contribution of different components of these multicomponent 
support systems aiming to improve selected outcomes. As cancer patients 
experience their illness primarily through symptoms, reduction of symptom distress, 
anxiety, and depression are important indicators of the success of illness 
management support. Furthermore, there is a need to test the effects of Web-based 
support as a part of regular care. 
The aims of the study were therefore to test and compare the effects of (1) an IPPC, 
(2) the multicomponent WebChoice intervention (including an IPPC), and (3) usual 
care (control group) on symptom distress, anxiety, and depression (primary 
outcomes), as well as self-efficacy (secondary outcome) after 6 months of follow-up. 
In addition, explorative sub-analyses were performed to detect whether the outcomes 
were associated with the actual use of the interventions. We hypothesized that the 
WebChoice group compared with the usual care group would have better outcomes 
than the IPPC group compared with the usual care group. We also hypothesized that 
both groups would have better outcomes than the usual care group, on both primary 
and secondary outcomes. 
Methods 
Subjects and Settings 
We conducted an RCT with three groups: two intervention groups (the IPPC service 
and WebChoice) and a usual care group (clinical trial NCT00971009). Due to slower 
recruitment than anticipated, we had to stop inclusion after 200 consenting 
participants, before the calculated sample was obtained. The current paper reports 
on 167 patients for whom 6-month follow-up data were available at the time this 
paper was written. These participants were recruited between May 2010 and 
September 2012. 
Inclusion criteria were recent diagnosis of breast cancer treated with surgery, or 
under treatment with radiation, chemotherapy, hormone therapy, or combinations of 
those (maximum 12 months after surgery), age over 18 years, able to write/read and 
speak Norwegian, having access to the Internet at home, and having a public key 
infrastructure (PKI) solution for secure system access. 
Study participants were recruited from three hospitals in Norway—one university 
hospital and two regional hospitals—at breast diagnostic centers or the ambulatory 
chemotherapy, radiation, and surgical units. Participants did not receive any 
incentives for participating in the study. 
See Multimedia Appendix 1 for the consent form and Multimedia Appendix 2 for the 
CONSORT-EHEALTH checklist [32]. 
Study Procedures 
Eligible patients scheduled for surgery or coming in for checkups after surgery or 
treatment were identified by the study nurses at the hospitals and provided with 
information about the study. Upon patients’ arrival at the clinic, the study nurses met 
the patients, provided brief information about the study, and asked if they were 
interested in participating. If the patients agreed, the nurse informed them about the 
study’s purpose and procedures and asked for written informed consent. Consenting 
patients completed baseline questionnaires before randomization. 
After completion of baseline questionnaires, patients were randomized according to a 
pre-defined automated computerized block randomization, with a block size of 42 
stratified by site. Due to the content of the interventions, patients could not be blinded 
to which arm they were randomized. 
Patients randomized to the usual care group were followed up as usual at the 
hospitals where they were treated. Patients who were randomized into the IPPC or 
WebChoice groups were informed and instructed in the use of the IPPC or 
WebChoice. They received a printed user manual with instructions for use, how to log 
on to the system, and an address and phone number to contact for help if needed. 
The only in-person information given was instructions on how to access the site and 
how to connect with the study support service if questions occurred. The study 
nurses showed them where in the user manual they could go to find information 
about how to access the site and how to connect with the study support service if 
needed. In addition, the participants were informed that they could use the IPPC or 
any component of WebChoice as much or as little as they liked and that using the 
system was entirely voluntary. The IPPC component was the same for both 
intervention groups. 
After being informed about group assignment, the patients were given access to the 
interventions the same day. They received an automatic welcome message when the 
system was ready to use. There was an option to be notified by text message or 
regular email when new messages appeared in the system. Most participants wanted 
this notification. All participants were sent questionnaires by postal mail at 2, 4, and 6 
months after enrolling. 
In total, 20 care providers answered questions from patients: a dedicated group of 
expert nurses (n=11) and physicians (n=6) in breast cancer care, and social workers 
(n=3) at the hospital where the patients were treated. They were thoroughly trained in 
administering the IPPC, technically as well as in codes of conduct for online 
communication with patients. There was a clear schedule for who was responsible for 
answering patients’ messages. The nurses were frontline and received all messages 
first. If necessary, they could forward the message to other care providers. If 
considered important, information from e-messages could be copied into the medical 
record and made available for other health care providers. When new questions 
arrived in the system, the recipient was notified through the hospital’s email system 
or by text message. The same providers answered e-messages from both the IPPC 
and WebChoice groups using the same interface. However, they were not entirely 
blinded to the intervention group assignment because this was sometimes disclosed 
by patients through the messages. The health care providers had no access to 
details about how patients used other components of WebChoice. They did not 
receive any reimbursement or additional dedicated time for answering secure e-
messages from the participants. 
The study was approved by the Regional Committee for Medical and Health 
Research Ethics and the Data Security Inspectorate in Norway. Written informed 
consent was obtained from all participants. All data were submitted to a secure 
server using an encrypted connection. Patients and health care personnel were 
authenticated using a public key solution that is currently used by Norwegian banks 
as a security platform. This means the users’ logon procedure is the same whether 
they log on to their online bank or to IPPC/WebChoice. Thus, patients did not need to 
learn a new procedure. 
The system experienced a 9-day period of downtime during the first year due to 
technical problems at the hospital server that hosted the application. No changes 
were made to the interventions during the trial period apart from fixing minor bugs. 
The interventions could be used from different Internet browsers and were 
independent of Internet connection speed. 
Description of the Two Interventions 
Internet-Based Patient-Provider Communication Intervention 
The IPPC is a further development of the IPPC component described in a previous 
study of WebChoice [18,33]. It allows patients to seek help from health care 
personnel at their treatment hospital. They can ask questions, share experiences 
with, or get advice from oncology nurses. If needed, the nurse can pass on their 
question to physicians and social workers (Figure 1). The system has a high security 
level, where both patients and health care providers log into the system with strong 
authentication keys. Care providers had access to the patients’ medical records at 
the hospital. The patient questions were asynchronous and were answered within 2 
work days (usually within 1 day). 
 
Figure 1. Message flow between patients and health care providers. View this figure 
WebChoice Intervention (Internet-Based Patient-Provider Communication Included) 
WebChoice was developed in close cooperation with users and health care 
personnel [31]. After testing the system in an RCT [18], it was refined based on 
responses from users through questionnaires and focus groups. In addition, a blog 
feature was included. The WebChoice version tested in the current study targeted 
breast cancer patients and contained the following components in addition to the 
IPPC service [34] (Figure 2): 
• An assessment component where patients could monitor their symptoms, 
problems, and priorities for support along physical, functional, and 
psychosocial dimensions. From a predefined list, patients could choose 
symptoms and problems they were experiencing, rate the burden of these, 
and indicate where they needed help. This information could be used to 
monitor improvement/deterioration of the condition, indicate when to alert 
health care personnel, prepare for a hospital/physician consultation, 
improve patient-provider communication, or obtain immediate access to 
the self-management advice components described below. 
• An advice component provided illness self-management support. The 
patients’ self-reported symptoms triggered the display of appropriate self-
management activities that patients could choose from to relieve 
symptoms and problems. The component could also be used without 
finishing an assessment first. Each choice contained an explanation of 
what the activity was, how to perform it, potential risks, side effects, 
contraindications, when to contact a physician, levels of evidence, 
references to the source of the evidence, and links to other reliable 
websites for related information. The advice component was updated once 
a year. 
• An information component where patients had access to other reliable 
Web sources in Norwegian and English, such as information about tests, 
treatments and potential side effects, lifestyle suggestions, and 
information about patients’ legal rights. External links were automatically 
checked every fourth week to ensure they were still active. 
• A communication component for sharing experiences with other patients. 
Patients could participate in an online forum group discussion that allowed 
them to exchange messages anonymously with other patients or use a 
blog. The forum and blog were monitored by nurses at our research 
center. The nurses did not participate in the forum or blog but answered 
two postings in the forum not answered by the other participants. 
• An electronic diary where patients could keep personal notes. 
 Figure 2. Screenshot of the WebChoice overview page. View this figure 
Measures and Data Collection 
Overview 
The primary outcomes were symptom distress, anxiety, and depression. The 
secondary outcome was self-efficacy. All outcomes were measured at baseline, 2, 4, 
and 6 months thorough self-assessed questionnaires sent to participants by postal 
mail. 
Demographic Characteristics 
Patients provided information on age, marital status, level of education, employment 
status, income, and the use of Internet services. 
Patient Characteristics 
The time of diagnosis and stage of disease were obtained from the medical record. 
Based on the patients’ tumor (T), node (N), and metastasis (M) classification at the 
time of diagnosis, the stage of disease was classified into 5 stages (0=ductal 
carcinoma in situ, to 4=advanced-stage disease) using the TNM Classification of 
Malignant Tumours of the Union for International Cancer Control guidelines [35]. 
Comorbidity 
Patients completed the Self-Administered Comorbidity Questionnaire (SCQ-19), 
which evaluated the number of, treatments for, and functional impact of health 
problems. It includes 16 common comorbidities and three optional conditions [36]. 
The total SCQ-19 score can range from 0-57 when the three optional items are used. 
It is a clinical scale, with established validity and reliability [36], for the assessment of 
comorbidities in patients with chronic medical conditions. A higher total score 
indicates a more severe comorbidity profile. 
Symptom Distress 
Symptom distress was measured by using the 32-item Memorial Symptom 
Assessment Scale (MSAS) [37], which lists physical and psychological symptoms 
that occur due to cancer or its treatment. For each symptom, patients were asked to 
indicate whether they had had the symptom during the previous week. If they had 
experienced the symptom, they were asked to rate its frequency, severity, and 
distress. Symptom frequency and severity was rated using a 4-point Likert scale. 
Symptom distress was rated using a 5-point Likert scale. The reliability and validity of 
the MSAS are well established [37], and MSAS has previously been used in breast 
cancer populations [38]. Higher scores indicate greater symptom distress. Cronbach 
alpha coefficient for our sample at baseline was .85. 
Anxiety and Depression 
Anxiety and depression were measured with the Hospital Anxiety and Depression 
Scale (HADS) [39], a 14-item, self-report measure of psychological distress. The 
HADS is divided into 2 subscales: anxiety (HADS-A) (7 items) and depression 
(HADS-D) (7 items). Respondents are asked to indicate which of 4 response options 
(rated from 0-3; score range, 0-42) comes closest to describing how they have been 
feeling in the previous week for each item. Scores from 0-7 on the subscales are 
regarded as being in the normal range; a score of 11 or higher indicates a probable 
presence of a mood disorder, and a score of 8-10 is suggestive of the presence of 
the state [40]. The scale is found to perform well in assessing the symptom severity 
of anxiety disorders and depression in hospital settings, in primary health care and in 
the general population [41], and has demonstrated acceptable reliability in cancer 
populations [42]. Cronbach alpha coefficient is reported to vary from .68-.93 for 
HADS-A, and for HADS-D from .67-.90 [41]. In our sample, Cronbach alpha at 




Self-efficacy was measured with the Cancer Behavioral Inventory (CBI) version 2.0 
[43], a 33-item instrument that measures coping self-efficacy with cancer-related 
stress on 7 dimensions: (1) maintenance of activity and independence, (2) seeking 
and understanding medical information, (3) stress management, (4) coping with 
treatment-related side effects, (5) accepting cancer and maintaining a positive 
attitude, (6) affective regulation, and (7) seeking support. Responses on 9-point Likert 
scales ranged from 1 (not at all confident) to 9 (totally confident). Higher scores 
indicated greater self-efficacy. CBI was used in a previous study testing WebChoice 
among breast and prostate cancer patients [18] and, according to Merluzzi et al, has 
good internal consistency with a Cronbach alpha coefficient reported of .94 [43]. 
Cronbach alpha coefficient for our sample at baseline was .96. 
System Use 
Data on system use were extracted from the user logs on the server. Information was 
collected on how many times the users had logged on and which components of 
WebChoice were accessed or used actively. 
Analysis 
Overview 
Data on baseline characteristics are presented as medians and ranges for 
continuous variables and as proportions with percentages for categorical data. 
Differences between users and non-users were analyzed using the chi-square test 
for pairs of categorical variables. The Mann-Whitney-Wilcoxon test was used for 
continuous data with skewed distributions. 
Effectiveness 
For analysis of between-group differences in symptom distress, anxiety, and 
depression (primary outcomes) and self-efficacy (secondary outcome), linear mixed 
models (LMM) for repeated measures were fitted. A diagonal covariance structure 
was used to model dependencies among measurements on the same individual at 
different time points. Models for each outcome consisted of 3 effects: measurement 
occasion (time), interventions (WebChoice, IPPC, usual care), and the interaction of 
time and intervention. All measured time points of the outcome variables are 
considered and the LMM approach therefore adjusts for baseline differences. To test 
whether potential confounders impacted the results, LMM adjusted for variables such 
as site, age, marital status, education, time since diagnosis, stage of disease, and 
comorbidity were fitted. Compared to the unadjusted models, these adjusted models 
revealed even larger differences in favor of the intervention groups compared to the 
usual care group. Taking the limited sample size into account and aiming to avoid 
over fitting, only the results from the unadjusted models are presented. As no 
statistically significant differences were observed between the study groups on 
demographic and disease-related factors at baseline, these models were not further 
adjusted for the possible confounders. The authors are aware that this might 
underestimate the true differences between the groups. Analyses of primary and 
secondary outcomes were conducted on an intention-to-treat basis, including all 
participants in each group, independent of whether they were users or non-users of 
the interventions. The model parameters are estimated using the classical maximum 
likelihood approach. No imputation of missing data was necessary or performed, as 
the LMM uses all data available to estimate the covariance matrix and model the 
dependencies. The results are presented as P values for the overall effect of the 
variables when baseline score and all time points are included. Moreover, overall 
mean differences are presented, that is, the difference between groups adjusted for 
baseline scores and taking all time points into consideration. Report of overall mean 
differences was chosen as we were interested in differences between the groups 
over the entire 6-month period. 
Explorative Sub-Analyses 
In addition, explorative sub-analyses were performed to detect whether the outcomes 
were associated with the actual use of the interventions. LMM for repeated measures 
were fitted. Models for each outcome were fitted with three factors: measurement 
occasion (time), interventions (user/non-user of WebChoice and IPPC), and the 
interaction of time and intervention. Age was added as a covariate because age is 
known to be associated with use of Web-based tools [44,45]. 
Analyses were carried out using SPSS version 18.0. P-values <.05 were considered 




The trial flow chart (Figure 3) shows the recruitment and retention at baseline and at 
2-, 4- and 6-month follow-up. From May 2010 to September 2012, 522 breast cancer 
patients were assessed for eligibility. Of these, 138 did not meet the inclusion criteria, 
mostly due to lack of Internet access, and 176 declined to participate. Non-
participants were slightly older; the median age among those who did not meet the 
inclusion criteria was 67 years and among those who declined to participate, 59 
years. Frequent reasons given for declining were lack of experience with computers/ 
Internet or that they had too much on their mind related to their illness. The 176 
patients who agreed to participate in the study were randomized after filling in 
baseline questionnaires. Nine patients were excluded due to incomplete baseline 
data, leaving a sample of 167. During 6 months of follow-up, we had a 14% (23/167) 
attrition rate. Information on reasons for withdrawal is not available. There was no 
association between baseline characteristics and those who left the study. At the 6-
month measurement, 62% (104/167) answered the questionnaires: WebChoice 62% 
(40/64), IPPC 57% (25/45), and usual care group 67% (39/58). 
 
Figure 3. Flow of participants throughout the trial. View this figure 
Baseline Characteristics 
There were no statistically significant differences in demographics, disease-related 
factors, or outcome measures between participants in the three groups at baseline 
(Table 1). 
 Table 1. Baseline demographic and illness characteristics 
(n=167).View this table 
Effectiveness 
Figure 4 and Table 2 provide the patients’ self-reported scores for the primary 
outcomes of symptom distress, anxiety, and depression. When measurements at all 
four time points were included in the model, the WebChoice group reported 
significantly lower symptom distress over time (mean difference -0.16, 95% CI -0.25 
to -0.06, P=.001), anxiety (mean difference -0.79, 95% CI -1.49 to -0.09, P=.03), and 
depression (mean difference -0.79, 95% CI 1.18 to -0.05, P=.03) compared with the 
usual care group. Over time, the IPPC group had significantly lower depression 
scores compared with the usual care group (mean difference -0.69, 95% CI -1.32 to -
0.05, P=.03), but no differences were observed for symptom distress or anxiety. Time 
by condition interactions was examined, but no significant results detected. There 
were no statistically significant differences over time between the two intervention 
groups on symptom distress, anxiety, and depression (data not shown). 
The WebChoice group tended to score higher than the usual care group on self-
efficacy (secondary outcome) over time (mean difference 8.81, 95% CI -0.92 to 
18.53, P=.08) (Table 2 and Figure 4). No statistically significant differences were 
found over time between the IPPC group and the usual care group on self-efficacy. 
 Table 2. Effect of IPPC (n=45) and WebChoice (n=64) compared 
with the usual care group (n=58) on outcome variables: summary of basic mixed 
models.View this table 
 
 Figure 4. Estimated marginal means of (A) symptom distress (MSAS Total), (B) 
anxiety (HADS Anxiety), (C) depression (HADS Depression), and (D) self-efficacy 
(CBI Total) for the usual care group (n=58), the IPPC group (n=45), and the 
WebChoice group (n=64). View this figure 
System Use 
In accordance with the CONSORT-EHEALTH checklist [32], we analyzed the use of 
IPPC and WebChoice among those who had access to the applications. Among 
those randomized to the IPPC, 40% (18/45) sent at least an e-message and were 
defined as users (Table 3). In the WebChoice group, 77% (49/64) logged on at least 
once during the 6 months, and 39% (25/64) sent e-messages. We defined the two-
thirds (41/64) who accessed WebChoice more than once as users. We required 
patients to log in at least twice before we defined them as users because patients 
who logged in only once may have read only the welcome message and never 
actually used the system. The users logged on a median 7 times (range 2-41). 
Table 3 shows the use of the IPPC and the usage of different components in 
WebChoice among the users. Of the WebChoice users, 61% (25/41) sent e-
messages, 20% (8/41) posted in the discussion forum, and 37% (15/41) posted their 
own blogs. However, patients visited the IPPC, forum, and blog more often to read 
information without submitting their own postings. Reading of other blogs was the 
component most highly accessed (total 684; range 0-58, median 14). The advice 
components were also highly accessed (total 317; range 0-62; median 5). 
The IPPC messages were mainly answered by nurses within their regular working 
hours. Of the 153 messages sent by the respondents, 22% (33/153) were passed on 
to and answered by physicians. Only one message was passed on to social workers. 
Patient questions posed through the IPPC were always answered via secure e-
messages. In a few instances, the nurses informed the patient that they could contact 
her by phone to discuss issues voiced in the message. Time spent on answering 
messages was not measured. However, there were no indications that the nurses or 
physician felt the e-message answering task had been too time consuming for them 
during the study. 
There were no differences between users and non-users in either intervention group 
on any demographic or disease-related variables. 
 Table 3. Usage of components in WebChoice (n=41) and IPPC 
(n=18) over 6 months of access.View this table 
Exploratory Analysis: Effect of System Use on Outcomes 
No differences were detected between users and non-users of WebChoice or IPPC 
on symptom distress, depression, or self-efficacy (data not shown). The users of the 
IPPC had significantly lower scores on anxiety compared with the non-users (mean 
difference -1.28, 95% CI -2.54 to -0.01, P=.047). No such differences between users 
and non-users were observed in the WebChoice group (data not shown). 
Discussion 
Principal Results 
The current effectiveness study demonstrates that access to the multicomponent 
Web-based support system WebChoice for 6 months, among women with breast 
cancer within the first year after diagnosis, reduced symptom distress and levels of 
anxiety and depression scores. A tendency towards increased self-efficacy could also 
be detected for the WebChoice group. This is promising given three diverse practice 
settings in regular care. Also noteworthy is the finding that access to an IPPC alone 
reduced depression scores. These results support the hypothesis of the WebChoice 
group having better outcomes than the IPPC group in symptom distress and anxiety, 
compared to the usual care group. The IPPC group had a similar effect on reduction 
of depression as WebChoice, however, and the WebChoice group did not have 
better self-efficacy than the IPPC group compared to usual care. 
Our findings are in line with previous research showing that Web-based support 
systems in cancer populations can decrease depression and anxiety scores [17] and 
reduce symptom distress [18,19]. The reported effects in our study were detected 
despite a smaller sample size than initially calculated. However, in this study 
participants were more homogenous compared with the previously published study 
[18] that included both women with breast cancer and men with prostate cancer. In 
addition, the previous study included patients with recurrence of disease and 
metastasis, and patients were included independent of time since diagnosis (mean 
time since diagnosis 2.2 years), whereas patients in our study were included within 
the first year after diagnosis (median time since diagnosis 1 month). 
One possible explanation for our significant results might be that both WebChoice 
and IPPC might meet unmet needs reported by cancer patients, such as needs within 
the communication, information, psychosocial, psychological, and supportive care 
domains, generally highest during the treatment phase [46]. WebChoice allows 
patients to monitor their psychological, psychosocial, and physical symptoms and 
also get individually tailored information and support on how to manage their 
symptoms through the advice component. The information component can offer 
educational information through access to other reliable Web sources. Through 
WebChoice, patients are also able to read the information repeatedly when it suits 
them. Other studies suggests that Web-based information sources are used for 
different purposes [47] and that it can be easier to address sensitive information 
through email service than in personal encounters with health care professionals [25]. 
Offering self-management interventions in this early phase might be especially 
helpful. The need for early interventions was also supported by a study of an IPPC 
service similar to the one in the current study, where the need for such a service was 
described as being most prominent during the first phase after discharge from 
hospital [25]. 
Our results indicating that the IPPC reduced depression scores are especially 
promising, as depression is one of the most debilitating symptoms people can have 
and is highly prevalent among cancer patients [48,49]. This result was detected 
despite respondents being recruited from different settings with variations in 
organization of care, which holds promise for IPPCs as effective interventions for 
reduction of depression scores among breast cancer patients across settings. 
The IPPC’s ability to reduce depression scores might relate to indications that 
patients with higher scores of depression, in addition to higher symptom distress and 
low social support, are high users of the IPPC service in WebChoice [47]. As such, 
the IPPC is an intervention that is used by those with high illness burden, a group 
with high needs, and potential for improvement. The median baseline scores of both 
anxiety and depression were below the defined cut-off scores of 8, which is predictive 
for presence of anxiety and depression [40,41]. However, reduction of scores 
indicates that people are feeling better. Our limited sample size did not allow 
analyses on how the intervention affected the individuals who had scores of 8 or 
more. 
Whether the differences in effects of the IPPC and WebChoice are related to the 
additional features contained in WebChoice is not clear. The IPPC feature might be 
used differently in the two groups, and as such we were not able to fully disentangle 
the effect of the IPPC feature. The patients would have had to be allocated to 
separate conditions in order to test different features. However, as in the IPPC group 
where 40% (18/45) sent e-messages, 39 % (25/64) in the WebChoice group sent e-
messages, suggesting that interest in using this component is the same, independent 
of other features available. 
Use and Relation to Effects 
Use was not connected to the observed effects on symptom distress and depression 
in the current study. Similar results were observed in the previous study of 
WebChoice [18]. The findings that IPPC users had significantly lower scores on 
anxiety (P=.047) than the non-users must be interpreted with caution. The groups 
compared were small (18 users and 27 non-users), and thus the finding might be 
spurious. WebChoice is an illness management support system designed to support 
cancer patients in self-management of their illness. The system offers different 
components, so participants can use what they prefer without any push to use the 
system. Our findings of positive effects in the study despite user frequencies of just 
64% (WebChoice) and 40% (IPPC) might relate to the psychological effects of the 
sheer possibility of using the system when needed. Interviews with non-users of a 
similar IPPC revealed that even if they did not use the system, they liked having the 
possibility [50]. The assurance that someone is available and can answer the 
questions important to a patient may contribute to the effects observed on depression 
in the current study. The opportunity to get the information needed for self-
management of symptoms and problems, independent of time and location, might 
also contribute to the other findings of reduced symptom distress and anxiety. 
Limitations 
Several limitations need to be addressed. The first limitation concerns the small 
sample size. A larger sample would have increased the validity of the study but would 
also have prolonged the time needed for recruitment. In the recruitment process, 
most of the potential participants were approached. However, only a third of those 
approached were included. Lack of access to Internet, the most frequent reason for 
not meeting the inclusion criteria, was reported by 19% (98/522) of those 
approached. Among those who were eligible, a frequent reason given for declining 
participation was that patients judged their computer and Internet skills as poor. One 
way to increase the participation rates might be to offer a demonstration of the 
interventions at the time of inclusion. 
A smaller sample size than initially calculated and the attrition rate during the study 
reduced statistical power for our analyses. Because we had to stop inclusion of 
participants before the a priori calculated sample was obtained, block randomization 
led to different sample sizes in the three groups, with the least participants in the 
IPPC group. The project was also subject to high attrition during the study, which is 
not uncommon in studies of eHealth interventions [51]. In addition, the IPPC group 
had the lowest number of completers of questionnaires at 6 months. Our analysis 
should thus be interpreted with caution, and additional research is needed to confirm 
our results. 
Another limitation relates to low use of the interventions. The analyses of the 
intervention groups compared to the usual care group therefore compare the effects 
of a little used intervention. However, as the effects were detected through intention 
to treat analysis, the effect might be connected to the option and possibility of using 
the system, not necessarily to actual use. Our post hoc analyses of usage and its 
relation to outcomes were based on a smaller sample, comparing users and non-
users, and must be viewed as an exploratory analysis only. 
Interventions such as WebChoice, which offer components where people interact 
with each other (forum and blog), need a critical mass in order to be fully utilized. A 
study period of 6 months, an inclusion period of nearly 2.5 years, and the three-
armed study design resulted in few participants receiving the WebChoice intervention 
simultaneously. This could be an explanation for low use of the discussion forum in 
this study. 
Patients included in the study were younger (median age 52) than those who were 
excluded (median age 67) or who declined to participate (median age 59). In 
addition, the participants had higher education levels than the average level of 
education in Norway, suggesting that they were not representative of all age and 
educational groups among breast cancer patients. This, together with the small 
sample size, rate of declining participation, and the attrition from the study likely 
lowers the generalizability of the findings. On the other hand, the patients were 
recruited from three different hospitals across the country, which increased 
generalizability of findings across practice settings. Finally, nearly 50% of the 
participants were included right after the time of diagnosis. However, the other half 
was included at 1-10 months after diagnosis. As such, they were in different phases 
in their treatments and experienced different side effects at the time of questionnaire 
completion. This might have influenced the symptoms reported on the MSAS and 
HADS. On the other hand, this variability might strengthen our results. 
Implications 
This study illustrates the feasibility of offering parts of Web-based support systems in 
regular care, as the IPPC components were answered by nurses/physicians at the 
hospital where the patients were treated, providing the patients with easy access to 
the expertise, without a face-to-face appointment. The IPPC service, with its ability to 
reduce depression scores, will be an important component to integrate in Web-based 
support systems and can also be offered as a standalone system. 
The integration of Web-based support into clinical practice will require some 
changes, and changing routines in care is challenging [52-54]. There are reports of 
skepticism among care providers about use of IPPCs in routine care [55,56]. Some 
health care providers have expressed concerns that the use of e-messages might 
disrupt existing workflows and increase workloads [55]. Patients, however, expect to 
be able to communicate with their health care providers through e-messages 
[27,55,57], and integration of the IPPC (as a standalone service or as part of 
multicomponent support systems) does not require a huge change in health care 
routines. In this study, only a few nurses and physicians were trained to answer the 
IPPC. The number of e-messages in the study was moderate and most were 
answered by nurses, during their regular working hours. As such, the IPPC did not 
interfere with the workflow of the entire staff, and the number of e-messages was 
reported as manageable. The nurses answering the IPPC performed their new task 
during regular working hours, without any incentives. This indicates that it is feasible 
to implement IPPCs in regular care and that the service can be managed and 
answered by nurses. If clinicians recognize Web-based support as effective and 
easy-to-access resources for their patients’ self-management support and outcomes, 
they might be more receptive to these types of interventions or added service options 
[58]. 
In the current study, the e-messages were primarily answered by nurses and passed 
on to physicians only if needed, which indicates that the IPPC can successfully be 
managed by nurses on the front line. Nurses are described as having a holistic 
approach to patients, focusing on emotional issues, consequences of disease, and 
illness information [59]. They are thus well equipped to answer questions and 
concerns and are reported to be sensitive to and able to respond to patients’ 
emotions expressed through e-messages [60]. 
WebChoice, with all its features, had added effects compared with the IPPC alone. 
However, development and updating of systems such as WebChoice require far 
more resources than an IPPC service alone. Furthermore, IPPCs can be used for 
different patient groups independent of diagnosis, as the patient and provider are the 
ones who create the content. 
Further Research 
An aspect that remains to be tested is whether Web-based support systems are more 
effective when health care personnel with treatment responsibilities for the patients 
answer messages within the system, rather than health care personnel without this 
knowledge (patients can send e-messages anonymously). To obtain a deeper 
understanding of experience with the use of IPPC in routine care, we are currently 
interviewing nurses and physicians who have answered e-messages in this study. 
This experience is important to guide the implementation processes in the future. In 
addition, as most studies report on services between patients and physicians, more 
research is needed to test similar services managed by nurses. Finally, the positive 
effects on patients’ outcomes, despite moderate user frequencies and almost no 
differences detected between users and non-users, calls for further research 
examining how the psychological effect of simply having access to information and 
support might impact outcomes. 
Conclusions 
In spite of the practice variations at three different hospitals, and moderate use of the 
IPPC service and WebChoice by study patients, our preliminary results suggest that 
offering Web-based support as a part of regular practice can be a powerful tool to 
help patients manage their illness. Our finding that the nurse-administered IPPC 
alone significantly reduced depression, a highly debilitating symptom, is particularly 
promising, as an IPPC can be implemented in different settings. However, the 
multicomponent support system, WebChoice, had additional positive effects on 
reducing anxiety symptoms and symptom distress. 
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CBI: Cancer Behavioral Inventory 
IPPC: Internet-Based Patient Provider Communication service 
HADS: Hospital Anxiety and Depression Scale 
LLM: linear mixed model 
MSAS: Memorial Symptom Assessment Scale 
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